- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04874415
Behavioral Economics for Activity Motivation in Adolescents (BEAM)
April 3, 2024 updated by: Mary Ellen Vajravelu, MD, University of Pittsburgh
Behavioral Economics for Activity Motivation in Adolescents and Young Adults With Prediabetes and Type 2 Diabetes
There is an urgent need to engineer targeted physical activity interventions that are effective and scalable for obese adolescents and young adults (AYA) with type 2 diabetes (T2D), who often have very low levels of physical activity.
The BEAM Trial is a proposed mobile health (mHealth) intervention that uses behavioral economic-informed financial incentives and text messaging to promote physical activity in AYA with T2D and prediabetes.
Study Overview
Status
Recruiting
Study Type
Interventional
Enrollment (Estimated)
75
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mary E Vajravelu, MD
- Phone Number: 412-692-6533
- Email: MaryEllen.Vajravelu@pitt.edu
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15224
- Recruiting
- UPMC Children's Hospital of Pittsburgh
-
Contact:
- Mary E Vajravelu, MD
- Phone Number: 412-692-6533
- Email: MaryEllen.Vajravelu@pitt.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years to 22 years (Child, Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- 1) Males or females age 13 to 22 years.
- 2) Overweight or obese (BMI ≥85th percentile for age/sex, or ≥25 kg/m2 for participants ≥18 years)
- 3) Diagnosis with prediabetes or type 2 diabetes
- 4) Consent (subjects 18 and older), Parental/guardian permission (subjects 13-17), assent (subjects 13-17)
- 5) Willingness to wear Fitbit during waking hours daily for duration of run-in and intervention.
- 6) Possession of a smartphone.
Exclusion Criteria:
- 1) Potential subject unable to speak or read in English
- 2) Severe cognitive impairment
- 3) Permanent or temporary physical disability that impairs ambulation or precludes engagement in MVPA
- 4) Current pregnancy
- 5) Previously-diagnosed or current restrictive or purging eating disorder
- 6) Moderate to vigorous physical activity (MVPA) >30 minutes per day or Fitbit wear < 4 days during second week of 2-week run-in period
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Condition 1
1RLD=One text per day, ramped goal, loss incentive, daily goal time period.
|
1RLD=One text per day, ramped goal, loss incentive, daily goal time period
|
Experimental: Condition 2
1RLW=One text per day, ramped goal, loss incentive, weekly goal time period.
|
1RLW=One text per day, ramped goal, loss incentive, weekly goal time period.
|
Experimental: Condition 3
1RGD=One text per day, ramped goal, gain incentive, daily goal time period.
|
1RGD=One text per day, ramped goal, gain incentive, daily goal time period.
|
Experimental: Condition 4
1RGW=One text per day, ramped goal, gain incentive, weekly goal time period.
|
One text per day, ramped goal, gain incentive, weekly goal time period.
|
Experimental: Condition 5
2RLD=Two texts per day, ramped goal, loss incentive, daily goal time period.
|
Two texts per day, ramped goal, loss incentive, daily goal time period.
|
Experimental: Condition 6
2RLW=Two texts per day, ramped goal, loss incentive, weekly goal time period.
|
Two texts per day, ramped goal, loss incentive, weekly goal time period.
|
Experimental: Condition 7
2RGD=Two texts per day, ramped goal, gain incentive, daily goal time period.
|
Two texts per day, ramped goal, gain incentive, daily goal time period.
|
Experimental: Condition 8
2RGW=Two texts per day, ramped goal, gain incentive, weekly goal time period.
|
Two texts per day, ramped goal, gain incentive, weekly goal time period.
|
Experimental: Condition 9
1FLD=One text per day, fixed goal, loss incentive, daily goal time period.
|
One text per day, fixed goal, loss incentive, daily weekly goal time period.
|
Experimental: Condition 10
1FLW=One text per day, fixed goal, loss incentive, weekly goal time period.
|
One text per day, fixed goal, loss incentive, weekly goal time period.
|
Experimental: Condition 11
1FGD=One text per day, fixed goal, gain incentive, daily goal time period.
|
One text per day, fixed goal, gain incentive, daily goal time period.
|
Experimental: Condition 12
1FGW=One text per day, fixed goal, gain incentive, weekly goal time period.
|
One text per day, fixed goal, gain incentive, weekly goal time period.
|
Experimental: Condition 13
2FLD=Two texts per day, fixed goal, loss incentive, daily goal time period.
|
Two texts per day, fixed goal, loss incentive, daily goal time period.
|
Experimental: Condition 14
2FLW=Two texts per day, fixed goal, loss incentive, weekly goal time period.
|
Two texts per day, fixed goal, loss incentive, weekly goal time period.
|
Experimental: Condition 15
2FGD=Two texts per day, fixed goal, gain incentive, daily goal time period.
|
Two texts per day, fixed goal, gain incentive, daily goal time period.
|
Experimental: Condition 16
2FGW=Two texts per day, fixed goal, gain incentive, weekly goal time period.
|
Two texts per day, fixed goal, gain incentive, weekly goal time period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Moderate to Vigorous Physical Activity (MVPA)
Time Frame: 12 weeks
|
Effects of time spent in MVPA will be measured by assessing the weekly mean minutes in MVPA per day
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Daily Step Count
Time Frame: 12 weeks
|
Daily step count will be measured by assessing the daily mean steps
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 16, 2021
Primary Completion (Estimated)
November 1, 2024
Study Completion (Estimated)
April 1, 2025
Study Registration Dates
First Submitted
April 30, 2021
First Submitted That Met QC Criteria
April 30, 2021
First Posted (Actual)
May 5, 2021
Study Record Updates
Last Update Posted (Actual)
April 4, 2024
Last Update Submitted That Met QC Criteria
April 3, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Glucose Metabolism Disorders
- Metabolic Diseases
- Neoplasms
- Endocrine System Diseases
- Ovarian Cysts
- Cysts
- Ovarian Diseases
- Adnexal Diseases
- Gonadal Disorders
- Diabetes Mellitus
- Hyperinsulinism
- Hyperglycemia
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Genital Diseases
- Genital Diseases, Female
- Diabetes Mellitus, Type 2
- Polycystic Ovary Syndrome
- Prediabetic State
- Glucose Intolerance
- Insulin Resistance
Other Study ID Numbers
- STUDY21040122
- K23DK125719-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Polycystic Ovary Syndrome
-
Cairo UniversityCompleted
-
Alexandria UniversityRecruitingPolycystic Ovary Syndrome (PCOS)Egypt
-
Saudi German Hospital - MadinahCompletedPolycystic Ovary Syndrome (PCOS)Saudi Arabia
-
University of CopenhagenCompletedPolycystic Ovary Syndrome (PCOS)Denmark
-
Odense University HospitalCompleted
-
Poznan University of Medical SciencesUniversity of California, DavisUnknownPolycystic Ovary Syndrome (PCOS)Poland
-
Mansoura UniversityNot yet recruitingPCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
-
Assaf-Harofeh Medical CenterUnknownInfertility | Polycystic OvariesIsrael
-
Riphah International UniversityCompleted
-
Dexa Medica GroupCompletedPolycystic Ovary Syndrome (PCOS)Indonesia